Research · IEEE Spectrum AI ·
How a Google DeepMind Spinoff Hunts Hidden Drug Targets
IEEE Spectrum reports that Isomorphic Labs, a Google DeepMind spinout, is building tools to find protein binding pockets and predict protein-drug interactions for drug discovery. The company has partnerships with Novartis and Eli Lilly, raised $2.1 billion, and published a technical report on its Isomorphic Drug Design